Individuals with autism spectrum disorders (ASDs) have language and behavioural abnormalities, and can suffer from other symptoms, including epileptic seizures. Many genes have been associated with ASDs, one of which is *CNTNAP2,* encoding a neuronal transmembrane protein. Mutations in *CNTNAP2* are strongly associated with an ASD known as cortical dysplasia-focal epilepsy (CDFE). Peñagarikano and colleagues developed *Cntnap2*-knockout mice to investigate the mechanistic basis for this association in vivo. They found that these mice have normal stress responses and visual spatial memory, but exhibit abnormal social, language and repetitive behaviours, resembling those seen in individuals with ASDs. In addition, mutant mice are hyperactive and suffer epileptic seizures similar to patients with CDFE. Analysis of brain circuitry prior to the onset of seizures revealed that *Cntnap2*-knockout mice have neuronal migration abnormalities and reduced network activity, suggesting that *CNTNAP2* is involved in early brain development. Treatment of the mice with the FDA-approved drug Risperidone -- which is used to reduce behavioural problems in individuals with ASDs -- ameliorated behavioural defects in *Cntnap2*-knockout mice. This study provides new insight into the mechanism of an ASD-associated gene and suggests that the *Cntnap2*-knockout mouse is a valuable model for testing candidate drugs for these disorders.
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